A multiplex PCR method was developed to identify simultaneously multiple fungal pathogens in a single reaction. Five sets of species-specific primers were designed from the internal transcribed spacer (ITS) regions, ITS1 and ITS2, of the rRNA gene to identify Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Aspergillus fumigatus. Another set of previously published ITS primers, CN4 and CN5, were used to identify Cryptococcus neoformans. Three sets of primers were used in one multiplex PCR to identify three different species. Six different species of pathogenic fungi can be identified with two multiplex PCRs. Furthermore, instead of using templates of purified genomic DNA, we performed the PCR directly from yeast colonies or cultures, which simplified the procedure and precluded contamination during the extraction of DNA. A total of 242 fungal isolates were tested, representing 13 species of yeasts, four species of Aspergillus, and three zygomycetes. The multiplex PCR was tested on isolated DNA or fungal colonies, and both provided 100% sensitivity and specificity. However, DNA from only about half the molds could be amplified directly from mycelial fragments, while DNA from every yeast colony was amplified. This multiplex PCR method provides a rapid, simple, and reliable alternative to conventional methods to identify common clinical fungal isolates.
Invasive mycoses have become a major cause of infectious morbidity and mortality in patients receiving immunosuppressive chemotherapy for cancer or organ transplantation or in immunodeficient patients, such as individuals with AIDS (2, 6, 7, 9, 20, 26) . Since opportunistic mycoses are often grave, the early, rapid, and accurate identification of the pathogenic fungus is critical for timely, appropriate management. The conventional identification of pathogenic fungi in the clinical microbiology laboratory is based on morphological and physiological tests, often requires 3 or more days, and may be inaccurate (12, 14) .
In recent years, numerous DNA-based methods have been developed to improve the diagnosis of mycotic infections and the identification of pathogenic fungi (13, 27, 34, 37, 45) . PCR methods are particularly promising because of their simplicity, specificity, and sensitivity. For example, PCR methods targeting different genes have been described elsewhere for identification of Cryptococcus neoformans (39) , Aspergillus fumigatus (19, 36) , and species of Candida (4, 5, 11, 15, 28-30, 33, 37, 42, 48) . A number of studies have described probes, restriction fragment length polymorphism, or other methods to identify unique ribosomal DNA (rDNA) sequences (10, 16-18, 22, 23, 32, 40, 41, 43) . The most common approaches have targeted portions of the rDNA of species of Candida (3, 8, 10, 31, 38, 44) . Although these published PCR methods have been useful for the identification of fungal species, they either identify only one species at a time or require a probe hybridization procedure that incurs time and expense.
We describe here a sensitive and specific method to rapidly and simultaneously identify the most common pathogenic fungi in tandem multiplex PCRs. The method combines three species-specific primers in a single PCR tube. To obtain genomic DNA template, we demonstrate that a colony can be sampled directly from a pure culture. Primers CGL1-CGL2, CTR1-CTR2, and CPA1-CPA2 were combined in one multiplex PCR to identify Candida glabrata, Candida tropicalis, and Candida parapsilosis, respectively (multiplex G-T-P); primers AFUM1-AFUM2, CALB1-CALB2, and CN5-CN4 were combined in another multiplex PCR to identify A. fumigatus, Candida albicans, and C. neoformans, respectively (multiplex F-A-N). In a separate PCR, the ITS1-ITS4 primer pair provided a positive control to monitor the amplification of all fungal samples (47) .
MATERIALS AND METHODS
Fungal isolates. Most of the yeast strains and samples of A. fumigatus were isolated from clinical specimens at Duke University Medical Center and maintained in the collection of the Duke Medical Mycology Research Laboratory. The identification of all isolates was confirmed by conventional morphological and physiological methods (1, 35, 46) . The samples of C. albicans included one isolate that was identified as Candida stellatoidea, which we deemed a variant of C. albicans (24) . To provide a spectrum of medical fungi related to many of the target species, a total of 242 isolates were analyzed, including 10 species of Candida (181 isolates), 4 species of Aspergillus (38 isolates), 3 zygomycetous species (9 isolates), and 3 other yeast species: C. neoformans (10 isolates), Saccharomyces cerevisiae (3 isolates), and Kluyveromyces marianum (1 isolate). A rather large sampling of C. parapsilosis was available because of a concurrent study in which we obtained isolates from the oral cavities and fingernails of healthy undergraduate and medical students of Duke University and the University of North Carolina at Chapel Hill. Control isolates of C. parapsilosis groups I, II, and III were obtained from Paul F. Lehmann (21) . A pure culture of each isolate was obtained by streaking the liquid culture on yeast extractpeptone-dextrose agar plates and grown overnight at 30°C.
DNA isolation. For DNA extraction, a single colony was transferred to a yeast extract-peptone-dextrose plate and grown overnight at 30°C, followed by DNA isolation as described previously (49) . For direct yeast cell amplification, a single colony approximately 1 mm in diameter was picked with a micropipette tip, suspended in 5 l of sterile, distilled water in a microcentrifuge tube, and vortexed; then, 0.5 l of this suspension was used in the PCRs. Molds were cultured for at least 5 days to produce a visible colony, and a tiny portion of the colony was transferred directly to the PCR tube. We also tested molds that had been stored for more than 1 year.
Primer design. Species-specific primer pairs-CGL1-CGL2, CTR1-CTR2, CPA1-CPA2, CALB1-CALB2, and AFUM1-AFUM2-were designed based on the sequence data for the internal transcribed spacer (ITS) region (Table 1) in the GenBank database to specifically amplify C. glabrata, C. tropicalis, C. parapsilosis, C. albicans, and A. fumigatus, respectively. The forward primers (primer 1 of each pair) were designed within the ITS1 region, and the reverse primers (primer 2) were designed from the ITS2 region. The C. neoformans-specific primers CN5 and CN4 were previously described (25) . The universal fungal primers ITS1 and ITS4 provided a positive PCR control (47) .
PCR. For PCR with individual primer pairs, each reaction mixture contained 2 l (ϳ1 ng) of diluted genomic DNA template or 0.5 l of yeast cell suspension, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM (each of the four) deoxyribonucleotide triphosphates, 0.5 M (each) primer, and 0.5 U of Taq DNA polymerase (Invitrogen Life Technologies, Carlsbad, Calif.) in a total volume of 20 l. PCR amplification conditions were 5 min of denaturation at 96°C, followed by 40 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s and a final extension step of 72°C for 15 min. A sample of 10 l of product from each PCR was electrophoresed in a 1.5% agarose gel with 0.5 g of ethidium bromide/ml and 1ϫ Tris-acetate-EDTA buffer for 1 to 2 h. DNA bands were visualized on a UV transilluminator and documented with an Alpha-Imager 2000 (Alpha Innotech, San Leandro, Calif.).
Multiplex PCR. A total of six species were tested in two multiplex PCR panels. Each multiplex panel contained three pairs of primers that were designed and comixed to produce amplicons sufficiently different in size and migration to identify three fungal species. The multiplex G-T-P panel contained primers that identified C. glabrata, C. tropicalis, and C. parapsilosis, and the F-A-N multiplex panel included primers that are specific for A. fumigatus, C. albicans, and C. neoformans. Primer sequences are presented in Table 1 . The G-T-P multiplex PCR contained 0.7 M primers CGL1 and CGL2, 0.4 M primers CTR1 and CTR2, and 0.6 M primers CPA1 and CPA2. The F-A-N multiplex PCR contained 0.5 M (each of the following) primers AFUM1, AFUM2, CALB1, CALB2, CN5, and CN4 (Table 1 ). The 20-l PCR mixtures contained 0.75 U of Taq DNA polymerase; all other reagents were the same as described above for single-primer-pair PCRs. The PCR tubes were kept on ice, and the PCRs were carried out in a Perkin-Elmer model 9700 thermal cycler preequilibrated at 96°C to provide a hot start. All PCRs were run with the same cycling program used for single-primer-pair PCR (described above). PCR products were electrophoresed in a 2% agarose gel with ethidium bromide for 2 to 3 h and evaluated as described above.
RESULTS
To determine the sensitivity and specificity of the PCR primers, each primer set was first tested with serial dilutions of PCR products from the corresponding species. Figure 1 shows a representative serial dilution of the PCR products (amplicons) with primers ITS1-ITS4, CGL1-CGL2, CTR1-CTR2, and CPA1-CPA2. The sensitivity of each set of primers ranged from 100 to 1,000 DNA molecules, which indicates the potential to amplify the appropriate amplicon from purified genomic DNA from 1 to 10 yeast cells.
For multiplex PCR, three sets of primers were combined in a single tube to simultaneously identify three fungal pathogens. A total of six primer sets were used in two different multiplex PCR panels, as noted above and illustrated in Fig. 2 . Multiplex G-T-P contained primer sets CGL1-CGL2, CTR1-CTR2, and CPA1-CPA2. Multiplex F-A-N consisted of primers AFUM1-AFUM2, CALB1-CALB2, and CN5-CN4. As shown in Fig. 2 , both G-T-P and F-A-N multiplex PCRs generated specific amplicons of the correct sizes when templates from the corresponding species were present. When all three templates were included in each panel, three products of the signature size were correctly produced (Fig. 2, top, lane 13, and bottom, lane  14) . The sensitivity of the multiplex PCR was similar to the sensitivity of single-primer-set PCR. These results indicate that up to three suspected pathogens can be identified in a single PCR. 
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To further simplify the procedure and shorten the time required for identification, we explored the possibility of performing multiplex PCR directly from yeast colonies, bypassing the usual, time-consuming DNA isolation steps. All multiplex PCR conditions were the same as described above except that, instead of extracted DNA, the template consisted of 0.5 l of a suspension of yeast cells or fragments of hyphae. As shown in Testing both individual primer pairs and multiplex PCR methods and using either extracted genomic DNA or a suspension of yeast cells as the template, we evaluated a total of 242 fungal strains ( Table 2) . As expected, the universal fungal primers, ITS1-ITS4, produced an amplicon of the appropriate size (Fig. 1A ) from all the yeasts and about half the molds that were directly assayed. Older mold colonies were less likely to produce the universal amplicon than were fresh cultures. Since every isolate of C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. neoformans that was tested generated only species-specific products, their sensitivity was 100%. All isolates of A. fumigatus that could be amplified directly from hyphae (13 of 15 strains) also exhibited a sensitivity of 100%. The CALB1-CALB2 primer pair was positive for all 26 strains of C. albicans. Since all isolates of Candida dubliniensis, Candida guilliermondii, Candida kefyr, Candida krusei, Candida lusitaniae, Candida pichia, K. marianum, and S. cerevisiae tested negative with each of the six species-specific primer pairs, the specificity was 100%. There are at least three subgroups of C. parapsilosis (21) . The first primer pair that we designed, CPA1-CPA2 (Table 1), amplified only isolates of group I, whereas the newly designed primer pair CPA3-CPA2 amplifies isolates from all groups of C. parapsilosis.
DISCUSSION
From the multicopy rRNA gene sequences, we designed six pairs of species-specific primers to amplify frequently encountered opportunistic pathogenic fungi (Table 1) . We then developed a multiplex PCR protocol to rapidly and simultaneously identify these six species: A. fumigatus, C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. neoformans. All 173 isolates of the five yeast species and 13 of 15 isolates of A. fumigatus that were tested produced the signature amplicon, based on migration in agarose gels and comparison with positive controls (Table 2 and Fig. 2 and 3 ). (Two isolates of A. fumigatus could not be amplified directly from hyphae.) Among the 54 isolates of 14 related species that were tested, there were no false-positive PCR tests (Table 2 ).
In addition, we describe the use of whole yeast or hyphal cells as template for the PCRs. Omission of the DNA extraction procedure significantly decreases the time required to make an accurate identification by PCR. Although fungal cell breakage and the release of genomic DNA are undoubtedly less efficient without the preliminary extraction of DNA, adequate template was nevertheless available to yield positive PCR tests. Whole cells from all 195 yeast isolates, representing 13 species, yielded positive products with the universal fungal primers ITS1-ITS4 (Table 2 ). However, only 53.2% (25 of 47) of the molds produced amplicons directly from hyphal frag- We have also been able to amplify fragments of many singlecopy genes from several species of Candida (data not presented). For many purposes, this quick method has become routine for the amplification of DNA from cultures of yeast species. The molds were much less amenable to direct amplification, perhaps because of more intractable cell walls, abundant endogenous nucleases, inhibitors of the PCR, or other factors. There was a tendency for younger mold cultures to be more PCR positive than older cultures. We are currently designing specific pairs of primers and multiplex PCR formats to identify additional medically relevant fungi. We are also applying these primers to the detection of pathogenic fungal DNA in clinical specimens.
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